UNDERWRITING AGREEMENT betweenUnderwriting Agreement • June 19th, 2020 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
As Representative of the several Underwriters named on Schedule 1 attached hereto 590 Madison Avenue, 36th Floor New York, New York 10022
RECITALS:Asset Purchase Agreement • October 20th, 2004 • Clicknsettle Com Inc • Services-business services, nec • New York
PRE-FUNDED COMMON STOCK PURCHASE WARRANT biocardia, INC.BioCardia, Inc. • June 15th, 2020 • Biological products, (no disgnostic substances) • New York
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioCardia, Inc., Inc., a Delaware corporation (the “Company”), up to ______ shares of common stock, par value $0.001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECOND AMENDMENT TO LEASELease • September 27th, 1999 • Nam Corp • Services-legal services
EXHIBIT 4.1 STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT (the "Agreement"), dated as of this 10th day of May, 2000, by and between NAM Corporation, a Delaware corporation (the "Company"), with offices located at 1010 Northern Boulevard,...Stock Purchase Agreement • May 17th, 2000 • Nam Corp • Services-legal services • New York
EXHIBIT 4.2 NEITHER THIS WARRANT NOR THE SHARES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR ANY OTHER APPLICABLE SECURITIES LAWS IN RELIANCE UPON AN EXEMPTION FROM THE...Nam Corp • May 17th, 2000 • Services-legal services
COMMON STOCK PURCHASE WARRANT BIOCARDIA, INC.Common Stock Purchase Warrant • August 7th, 2019 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_____________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on August 6, 2024 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioCardia, Inc., a Delaware corporation (the “Company”), up to [ ] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, subject to a Holder’s right to
FORM OF SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 16th, 2023 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of November 16, 2023, between BioCardia, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Exhibit 10.2 EMPLOYMENT AGREEMENT This AGREEMENT (the "Agreement"), dated as of March 15, 2002, is made by and between ROY ISRAEL (the "Executive") and CLICKNSETTLE.COM, INC., a Delaware corporation (the "Company"). WHEREAS, the Executive is currently...Employment Agreement • September 26th, 2002 • Clicknsettle Com Inc • Services-business services, nec
BioCardia, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • April 12th, 2022 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
BioCardia, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
EXHIBIT C REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT, dated as of February 16, 2000, between Moldbury Holdings Limited ("Investor"), and NAM Corporation, a corporation incorporated under the laws of the State of Delaware (the...Registration Rights Agreement • March 28th, 2000 • Nam Corp • Services-legal services • New York
PURCHASE AGREEMENTPurchase Agreement • March 29th, 2021 • BioCardia, Inc. • Biological products, (no disgnostic substances) • Illinois
PURCHASE AGREEMENT (the “Agreement”), dated as of March 29, 2021, by and between BIOCARDIA, INC., a Delaware corporation, (the “Company”), LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”).
BIOCARDIA, INC. (f/k/a TIGER X MEDICAL, INC.) INDEMNIFICATION AGREEMENTIndemnification Agreement • October 27th, 2016 • BioCardia, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
This Indemnification Agreement (this “Agreement”) is dated as of ____________ (the “Effective Date”), and is between BioCardia, Inc., a Delaware corporation (the “Company”), and _______________________ (“Indemnitee”).
BioCardia, Inc.BioCardia, Inc. • December 16th, 2020 • Biological products, (no disgnostic substances) • New York
EXHIBIT C REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT, dated as of February 15, 2000, between the investor or investors signatory hereto (each an "Investor" and together the "Investors"), and NAM Corporation, a Delaware...Registration Rights Agreement • March 28th, 2000 • Nam Corp • Services-legal services • New York
AT THE MARKET OFFERING AGREEMENTMarket Offering Agreement • December 6th, 2023 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
BioCardia, Inc., a corporation organized under the laws of Delaware (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (the “Manager”) as follows:
NEITHER THIS WARRANT NOR THE SHARES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR ANY OTHER APPLICABLE SECURITIES LAWS IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION...Nam Corp • April 21st, 2000 • Services-legal services
Exhibit 10.11 BUSINESS & ------------------------------------------------------ -------------------------- BUSINESS CHECKING PLUS AGREEMENT PROFESSIONAL ------------------------------------------------------------------------------- Name of Borrower |...Nam Corp • October 3rd, 1996 • Services-legal services • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 29th, 2024 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August [__], 2024, between BioCardia, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
AGREEMENTAgreement • October 14th, 1997 • Nam Corp • Services-legal services
BIOCARDIA, INC.Stock Option Agreement • October 27th, 2016 • BioCardia, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • California
Unless otherwise defined herein, the terms defined in the 2016 Equity Incentive Plan (the “Plan”) shall have the same defined meanings in this Stock Option Agreement (the “Option Agreement”).
RECITALSAdvertising Agreement • September 28th, 2004 • Clicknsettle Com Inc • Services-business services, nec • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 27th, 2018 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 24, 2018, between BioCardia, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
BIOCARDIA, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • July 23rd, 2019 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
The undersigned, BioCardia, Inc., a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters;”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), an aggregate of ______________ units (the “Firm Units” or “Units”) of the Company’s securities, and, at the election of the Representative, up to an additional ____________ Option Shares (as defined herein and collectively with the shares of Common Stock underlying the Firm Units, the “Shares”), and/or up to an additional ___________ Option Warrants (as defined herein and collectively with warrants underlying the Firm Units, the “Warrants”). Each Unit consists of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”) and one Warrant. Each Warrant entitles the holder to purcha
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 29th, 2021 • BioCardia, Inc. • Biological products, (no disgnostic substances) • Illinois
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 29, 2021, by and between BIOCARDIA, INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with its permitted assigns, the “Investor”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
PRIVATE EQUITY LINE OF CREDIT AGREEMENTCredit Agreement • March 28th, 2000 • Nam Corp • Services-legal services • New York
August 11, 2003 Mr. Alan Littman 83 Shepherd Lane Roslyn Heights, New York 11577 Re: Offer of Employment Dear Alan: clickNsettle.com, Inc., a Delaware corporation, (the "Company"), and its wholly-owned subsidiaries, extend to you an offer of...General Release and Agreement • September 25th, 2003 • Clicknsettle Com Inc • Services-business services, nec • New York
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 29th, 2009 • Cardo Medical, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
BIOCARDIA, INC. RESTRICTED STOCK UNIT AGREEMENTRestricted Stock Unit Agreement • February 8th, 2017 • BioCardia, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • California
Unless otherwise defined herein, the terms defined in the BioCardia, Inc. 2016 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Restricted Stock Unit Agreement (the “Award Agreement”), which includes the Notice of Restricted Stock Unit Grant (the “Notice of Grant”) and the Terms and Conditions of Restricted Stock Unit Grant, attached hereto as Exhibit A.
AGREEMENTEmployment Agreement • September 28th, 1998 • Nam Corp • Services-legal services
STOCK OPTION AGREEMENTStock Option Agreement • February 8th, 2017 • BioCardia, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • California
Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Option Agreement.
AMENDMENT TO CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • August 9th, 2024 • BioCardia, Inc. • Biological products, (no disgnostic substances)
This Amendment to the Change in Control and Severance Agreement (the “Amendment”) is entered into by and between BioCardia, Inc. (the “Company”) and Peter Altman (“Executive”) (together, the “Parties,” or individually, a “Party”).
AMENDMENT TO CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • August 13th, 2024 • BioCardia, Inc. • Biological products, (no disgnostic substances)
This Amendment to the Change in Control and Severance Agreement (the “Amendment”) is entered into by and between BioCardia, Inc. (the “Company”) and Peter Altman (“Executive”) (together, the “Parties,” or individually, a “Party”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 16th, 2020 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 15, 2020, between BioCardia, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITY AGREEMENTSecurity Agreement • November 8th, 2010 • Cardo Medical, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • California
This Security Agreement, dated as of November 4, 2010, is made by and between Cardo Medical, Inc., a Delaware corporation (the “Debtor”), and Earl Brien, M.D., an individual (the “Secured Party”), with respect to the following facts:
